2020
Cxbladder Commercial Evaluation Confirms Clinical Outperformance
Peer reviewed publication of further independent, real-world clinical evidence highlights the effectiveness, safety and long term clinical utility from inclusion of Cxbladder in a new standard of care in mainstream clinical use. [read more]
Pacific Edge Featured on Bloomberg.com
Bloomberg.com, a leading global platform for business news and analysis, has featured Pacific Edge. [read more]
Pacific Edge Announces HY Financial Results
Pacific Edge is pleased to announce its half year results for the six months to 30th September 2020. It's been a transformational half year for the company with commercial agreements and accelerating revenue growth. [read more]
Interim Financial Result to be Announced 26 Nov
Pacific Edge would like to announce that half year results for the six months ending 30 September 2020 will be released on Thursday 26 November 2020, prior to 10am. [read more]
Pacific Edge Announces Executive Team Changes to Support Growth
An important personnel update for shareholders and investors. Pacific Edge is strengthening and expanding its executive team as the company positions itself for growth following the recent commercial milestones in the multi-billion dollar US healthcare market. [read more]
Pacific Edge Joins Top NZ Companies on S&P/ NZX 50 Index
S&P/ NZX 50 Indices have announced that Pacific Edge will replace Metlifecare on the NZX 50. [read more]
Video Footage of the 2020 Annual Shareholder Meeting is Now Available
Video footage of the Pacific Edge 2020 Annual Shareholder Meeting is now available to watch online. [read more]
Results of Pacific Edge 2020 Annual Meeting of Shareholders
At Pacific Edge’s Annual Shareholder Meeting, held online on the 5th August 2020, attendees were asked to vote on three resolutions, which were supported by the Board. [read more]
Pacific Edge 2020 Annual Shareholders Meeting
Speeches by our Chairman and CEO along with the presentation for today's meeting. [read more]
Pacific Edge Attracts Growth Capital at Market Premium
Pacific Edge is pleased to announce that it has accepted an investment offer of $22 million from ANZ New Zealand Investments, New Zealand’s largest manager of 3rd party money with NZ $33 billion funds under management. [read more]
Notice of Annual Shareholders Meeting
Pacific Edge advises that the 2020 Annual Meeting of Shareholders will be held at 3pm on Wednesday 5 August 2020. This will be a virtual meeting. [read more]
Pacific Edge Notified of Positive LCD Decision in USA
Transformational reimbursement milestone for Pacific Edge with the notification of LCD coverage for CMS patients in the USA. The LCD coverage facilitates reimbursement for CMS patients using Cxbladder Detect and Cxbladder Monitor. [read more]
Pacific Edge Annual Report 2020
Pacific Edge’s Annual Report for the year ended 31 March 2020 is now available for review. We invite you to read the document, along with our Annual Review Letter. [read more]
Kaiser Permanente Approves Commercial use of Cxbladder
It gives us great pleasure to announce that Pacific Edge Limited and Kaiser Permanente have reached an agreement for the commercial use of our Cxbladder tests. [read more]
Director Nomination Closing Date
We're pleased to confirm that the Pacific Edge Ltd Annual Shareholder Meeting will be held on 5 August 2020, with the closing date for Director nominations set for the 26 June. [read more]
Pacific Edge Reports Growth & Continued Progress in FY20
We're pleased to announce the release of our audited financial results for the 12 months ended 31 March 2020 (FY20). The results report continued growth and progress towards our commercial goals, with increased adoption and use of Cxbladder alongside substantial updates to our supporting base of peer reviewed publications. [read more]
Renowned US Oncologist & Author Recommends Cxbladder
Renowned Oncologist and Author Dr Mark Scholz discusses the benefits of Cxbladder as a substitute for cystoscopy during an interview on Prostate Cancer and the implications of blood in urine. [read more]
New Webinar: Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 and Beyond
In a discussion led by Neal Shore, MD, on the high profile UroToday platform, two influential urologists discuss their use of Cxbladder’s In-Home Sampling Programme and how it is currently being used by different urologists around the US to streamline patient care. [read more]
Cxbladder In-Home Sampling Program Discussed in BCAN Patient Webinar
In a webinar for patients and families, leading US urologist, Dr Sia Daneshmand, discusses Cxbladder in-home sampling as an option for patients with Stephanie Chisolm, Director of Education & Research for the US Bladder Cancer Advocacy Network (BCAN). [read more]
Cxbladder Added to LUGPA COVID-19 Resource Hub
Reference to Cxbladder’s in-home sampling programme has been added to the COVID-19 information hub as a cancer resource on the Large Urology Group Practice Association website in the USA. [read more]
Public Health Providers Increase Commercial Use of Cxbladder
Pacific Edge are pleased to announce that two of New Zealand’s largest public healthcare providers – Counties Manukau Health and Waitematā District Health Board - are extending their commercial use of Cxbladder. [read more]
Public Health Providers Roll-out Cxbladder In-home Sample Collection
New Zealand Public Health Providers Counties Manukau Health and MidCentral DHB (who combine to serve a population of approximately 805,000) are now dispatching Cxbladder test sample systems to patients at home. [read more]
Pacific Edge to Continue Providing Essential Diagnostic Services
Pacific Edge will continue to provide essential cancer diagnostic services during the COVID-19 shutdown in both New Zealand and USA. [read more]
Real World Evidence Highlights Clinical Utility of Cxbladder
Cancer diagnostics company, Pacific Edge Limited (PEB: NZX) has today announced the publication of further real world evidence of significant gains in clinical utility from the commercial adoption of Cxbladder Monitor (CxbM) by several of New Zealand’s public healthcare providers. [read more]
View our Calendar of Events
We welcome press and media enquiries. For further assistance, please feel free to contact us.